The literature on the association between anti-TNF-α therapy and the risk of lymphoma among patients with RA is characterized by a mix of observational studies, randomized controlled trials (RCTs), meta-analyses, and systematic reviews, which together show conflicting findings that sustain ongoing debate. Here, TNF is linked to rheumatoid arthritis.